Young Ro Byun

Title: Young Ro Byun: Innovator in Oral Pharmaceutical Compositions

Introduction

Young Ro Byun is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral drug delivery systems for anticancer agents. With a total of 3 patents, his work aims to improve patient compliance and reduce medical costs associated with cancer treatments.

Latest Patents

One of his latest patents is an oral pharmaceutical composition containing pemetrexed and a production method thereof. This invention relates to a formulation that enhances the oral bioavailability of pemetrexed, a water-soluble anticancer drug, by forming an ion-binding complex with a bile acid derivative. This innovative approach allows pemetrexed, which is typically administered via injection, to be provided in capsule or tablet form, thereby alleviating the inconvenience of injections and improving patient adherence to treatment.

Another significant patent by Young Ro Byun is an oral drug delivery composition containing oxaliplatin. This composition also utilizes a bile acid derivative to form an ionic complex, which is incorporated into a water-in-oil-in-water (w/o/w) multiple nanoemulsion. This method enhances the oral bioavailability of oxaliplatin, thus providing a more convenient alternative to injection and contributing to better patient compliance.

Career Highlights

Throughout his career, Young Ro Byun has worked with various companies, including Icure BNP Co., Ltd. and St Pharm Co., Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical formulations and drug delivery systems.

Collaborations

Young Ro Byun has collaborated with notable colleagues such as Jin Woo Park and Young Kweon Choi. These partnerships have likely contributed to the innovative advancements in his research and patent developments.

Conclusion

Young Ro Byun's contributions to the field of pharmaceuticals, particularly in oral drug delivery systems for anticancer agents, highlight his commitment to improving patient care. His innovative patents reflect a significant step forward in making cancer treatments more accessible and convenient for patients.